Dan Ouyang

Dan Ouyang

Biography

Dan Ouyang is a partner in our Capital Markets Practice Group. Dan has extensive experience with US and Hong Kong equity offerings, Rule 144A and Reg S bond offerings, and private equity and M&A transactions. She has represented corporate clients across a range of industries, including technology, healthcare, education and entertainment, in more than 100 IPOs and follow-on offerings in the US and Hong Kong.

Dan started her legal career in New York. Prior to joining Baker McKenzie Fenxun, she was the leader of the capital markets practice in an international law firm’s Greater China group. She was also a partner at another large international firm's Beijing office. She was previously a journalist at China Central Television and China Radio International.

Representative Legal Matters

Hong Kong Capital Markets

  • Represented Shenzhen Dobot Corp Ltd in its Hong Kong IPO and listing.
  • Represented underwriters in Black Sesame International Holding Limited’s Hong Kong IPO and listing.
  • Represented Baiwang Co., Ltd. in its Hong Kong IPO and listing.
  • Represented Dida Inc in its Hong Kong IPO and listing.
  • Represented WuXi XDC in its spin-off from Wuxi Biologics and its HK$4.07 billion Hong Kong IPO and listing.
  • Represented Xiamen Yan Palace Bird’s Nest Industry Co., Ltd. in its Hong Kong IPO and listing.
  • Represented Concord Healthcare Group Co., Ltd in its Hong Kong IPO and listing.
  • Represented Pu’er Lancang Ancient Tea Co., Ltd. in its Hong Kong IPO and listing.
  • Represented underwriters in ZX Inc.’s Hong Kong IPO and listing.
  • Represented underwriters in EDIANYUN Limited’s Hong Kong IPO and listing.

*includes matters handled prior to joining the Firm.

Professional Honors

  • Women Leader - IFLR1000,2024
  • Woman Lawyer of the Year - ALB, 2024
  • One of Asia’s “Top 15 Female Lawyers” - ALB, 2023
  • Highly regarded lawyer in capital markets - IFLR 1000, 2021-2023
  • One of China’s “Top 15 Female Lawyers” - ALB, 2021
  • Dealmakers of Asia – China (International Firms) - ALB, 2021-2023
  • China’s Elite Lawyers - China Business Law Journal, 2024
  • “The A-List” - China Business Law Journal, 2019-2023
  • Recognized in the 2021-2025 editions of Chambers Global, where sources praised that “Dan is more than an excellent lawyer; she is a strategist. She helps us navigate complex relationships among regulatory bodies, project intermediaries, investors and senior management, she always comes out with innovative solutions to address competing concerns.”
  • Finalist in International Dealmaker of the Year - China Law & Practice Awards, 2020, 2022
  • Recommended capital markets attorney (Greater China Guide) - The Legal 500, 2019-2024
  • Finalist for “IPO Lawyer of the Year” - The Asia Legal Awards, 2022-2023

Admissions

  • New York~United States (2006)
  • Hong Kong~China

Education

  • Cornell Law School (J.D.)
  • Cornell University (M.A.)
  • Peking University, Beijing, China (B.A.)

Languages

  • English
  • Mandarin
  • Speaker, “World, Law & Future,” Cornell University, January 2024
  • Panelist, “Cornell Women in Leadership: Strategies for Success and Driving Impact,” Cornell University, November 2023
  • Panelist, “The China Elite: Partners in Discussion,” The Legal 500 Webinars, June 2022
  • Speaker, E&Y China Healthcare Companies' IPO and related legal issues, November 2016
  • Speaker, PwC China Education Companies' IPO and related legal issues, May 2016
  • Speaker, China Medical Device Industry Annual Meeting, Medical Device Companies' HK IPO and related legal issues, April 2015